Trends & Forecasts

Margaret Hamburg, former FDA Commissioner, has led the agency through a period of increasing globalization.

Globalization has created an industrywide demand for regulatory harmonization. But who benefits?

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

Is age related to research productivity – and, if so, to what extent?

Record generic approvals, a joint opioid investigation... What’s new for pharma in business?

An exhibition in London explores the relationship between graphic design and health.

The future status of pharma intellectual property in the UK depends on the outcome of Brexit.

Serialization is far from simple, and many companies overlook key aspects

Sitting Down With… Abhijit Mukherjee, COO of Dr. Reddy's Laboratories, India

Keeping close ties, locking-up loopholes, and calculating costs… What's new for pharma in business?